Golimumab

Common brands: Simponi, Methotrexate, Rasuvo, Otrexup, Trexall

Top reporter: Janssen Biotech, Inc.

Tumor Necrosis Factor Blocker [EPC]Folate Analog Metabolic Inhibitor [EPC]Corticosteroid [EPC]Antirheumatic Agent [EPC]Selective T Cell Costimulation Modulator [EPC]
83,866
Total Reports
34,776
Serious Reports
6,164
Death Reports
30
Reported Reactions
Death Report Ratio: High (7.35%)

Patient Demographics

Male
17,153
Female
56,263

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for Golimumab.

# Reaction Reports % of Total
1 DRUG INEFFECTIVE 21,220
8.1%
2 RHEUMATOID ARTHRITIS 14,239
5.5%
3 PAIN 13,542
5.2%
4 FATIGUE 11,389
4.4%
5 OFF LABEL USE 10,168
3.9%
6 JOINT SWELLING 9,829
3.8%
7 ARTHRALGIA 9,797
3.8%
8 RASH 9,429
3.6%
9 ALOPECIA 9,372
3.6%
10 DRUG INTOLERANCE 8,890
3.4%
11 ABDOMINAL DISCOMFORT 8,759
3.4%
12 SWELLING 8,550
3.3%
13 SYSTEMIC LUPUS ERYTHEMATOSUS 8,434
3.2%
14 CONTRAINDICATED PRODUCT ADMINISTERED 8,345
3.2%
15 PEMPHIGUS 8,181
3.1%
16 GLOSSODYNIA 8,024
3.1%
17 ARTHROPATHY 7,718
3.0%
18 HYPERSENSITIVITY 7,537
2.9%
19 SYNOVITIS 7,260
2.8%
20 HAND DEFORMITY 7,027
2.7%
21 WOUND 6,730
2.6%
22 TREATMENT FAILURE 6,602
2.5%
23 INFUSION RELATED REACTION 6,369
2.4%
24 LOWER RESPIRATORY TRACT INFECTION 6,356
2.4%
25 CONDITION AGGRAVATED 6,262
2.4%
26 HEADACHE 6,246
2.4%
27 PRODUCT USE ISSUE 6,215
2.4%
28 THERAPEUTIC PRODUCT EFFECT DECREASED 6,208
2.4%
29 INFECTION 6,137
2.4%
30 PERIPHERAL SWELLING 6,034
2.3%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.